List of Tables
Summary Table: Global Market for Proteomic Technologies, by Region, Through 2030
Table 1: Global Incidence and Mortality Rates of Cancer, by Region, 2022
Table 2: Granted Patents in Proteomics Technologies, 2023-2025
Table 3: Global Market for Proteomics Technologies, by Platform Type, Through 2030
Table 4: Global Market for Mass Spectrometry, by Region, Through 2030
Table 5: Global Market for Biochips, by Type, Through 2030
Table 6: Global Market for Protein Microarrays, by Array Type, Through 2030
Table 7: Global Market for Biochips, by Region, Through 2030
Table 8: Global Market for Proteomic Technologies, by Application Type, Through 2030
Table 9: Drug Targets Identified by Proteomics
Table 10: Global Market for Proteomics in Drug Discovery and Development, by Platform Type, Through 2030
Table 11: Global Market for Proteomics in Drug Discovery and Development, by Region, Through 2030
Table 12: Examples of LC-MS/MS-based FDA-Approved Tests in Clinical Laboratories
Table 13: Global Market for Proteomics in Diagnostics, by Platform Type, Through 2030
Table 14: Global Market for Proteomics in Diagnostics, by Region, Through 2030
Table 15: Global Market for Proteomics in Diagnostics, by Disease Type, Through 2030
Table 16: Global Market for Proteomics in Research, by Platform Type, Through 2030
Table 17: Global Market for Proteomics in Research, by Region, Through 2030
Table 18: Global Market for Applied Proteomics, by Region, Through 2030
Table 19: Global Market for Proteomic Technologies, by Product Type, Through 2030
Table 20: Global Market for Consumables, by Region, Through 2030
Table 21: Global Market for Instruments and Software, by Region, Through 2030
Table 22: Global Market for Proteomic Technologies, by Region, Through 2030
Table 23: North American Market for Proteomic Technologies, by Platform Type, Through 2030
Table 24: North American Market for Biochips, by Type, Through 2030
Table 25: North American Market for Proteomic Technologies, by Application Type, Through 2030
Table 26: North American Market for Proteomic Technologies, by Product Type, Through 2030
Table 27: North American Market for Proteomic Technologies, by Country, Through 2030
Table 28: U.S. Market for Proteomic Technologies, by Platform Type, Through 2030
Table 29: U.S. Market for Proteomic Technologies, by Application Type, Through 2030
Table 30: U.S. Market for Proteomic Technologies, by Product Type, Through 2030
Table 31: Canadian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 32: Canadian Market for Proteomic Technologies, by Application Type, Through 2030
Table 33: Canadian Market for Proteomic Technologies, by Product Type, Through 2030
Table 34: Mexican Market for Proteomic Technologies, by Platform Type, Through 2030
Table 35: Mexican Market for Proteomic Technologies, by Application Type, Through 2030
Table 36: Mexican Market for Proteomic Technologies, by Product Type, Through 2030
Table 37: European Market for Proteomic Technologies, by Platform Type, Through 2030
Table 38: European Market for Biochips, by Type, Through 2030
Table 39: European Market for Proteomic Technologies, by Application Type, Through 2030
Table 40: European Market for Proteomic Technologies, by Product Type, Through 2030
Table 41: European Market for Proteomic Technologies, by Country, Through 2030
Table 42: German Market for Proteomic Technologies, by Platform Type, Through 2030
Table 43: German Market for Proteomic Technologies, by Application Type, Through 2030
Table 44: German Market for Proteomic Technologies, by Product Type, Through 2030
Table 45: U.K. Market for Proteomic Technologies, by Platform Type, Through 2030
Table 46: U.K. Market for Proteomic Technologies, by Application Type, Through 2030
Table 47: U.K. Market for Proteomic Technologies, by Product Type, Through 2030
Table 48: French Market for Proteomic Technologies, by Platform Type, Through 2030
Table 49: French Market for Proteomic Technologies, by Application Type, Through 2030
Table 50: French Market for Proteomic Technologies, by Product Type, Through 2030
Table 51: Italian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 52: Italian Market for Proteomic Technologies, by Application Type, Through 2030
Table 53: Italian Market for Proteomic Technologies, by Product Type, Through 2030
Table 54: Spanish Market for Proteomic Technologies, by Platform Type, Through 2030
Table 55: Spanish Market for Proteomic Technologies, by Application Type, Through 2030
Table 56: Spanish Market for Proteomic Technologies, by Product Type, Through 2030
Table 57: Rest of European Market for Proteomic Technologies, by Platform Type, Through 2030
Table 58: Rest of European Market for Proteomic Technologies, by Application Type, Through 2030
Table 59: Rest of European Market for Proteomic Technologies, by Product Type, Through 2030
Table 60: Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
Table 61: Asia-Pacific Market for Biochips, by Type, Through 2030
Table 62: Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
Table 63: Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
Table 64: Asia-Pacific Market for Proteomic Technologies, by Country, Through 2030
Table 65: Chinese Market for Proteomic Technologies, by Platform Type, Through 2030
Table 66: Chinese Market for Proteomic Technologies, by Application Type, Through 2030
Table 67: Chinese Market for Proteomic Technologies, by Product Type, Through 2030
Table 68: Japanese Market for Proteomic Technologies, by Platform Type, Through 2030
Table 69: Japanese Market for Proteomic Technologies, by Application Type, Through 2030
Table 70: Japanese Market for Proteomic Technologies, by Product Type, Through 2030
Table 71: Indian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 72: Indian Market for Proteomic Technologies, by Application Type, Through 2030
Table 73: Indian Market for Proteomic Technologies, by Product Type, Through 2030
Table 74: South Korean Market for Proteomic Technologies, by Platform Type, Through 2030
Table 75: South Korean Market for Proteomic Technologies, by Application Type, Through 2030
Table 76: South Korean Market for Proteomic Technologies, by Product Type, Through 2030
Table 77: Australian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 78: Australian Market for Proteomic Technologies, by Application Type, Through 2030
Table 79: Australian Market for Proteomic Technologies, by Product Type, Through 2030
Table 80: Rest of Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
Table 81: Rest of Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
Table 82: Rest of Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
Table 83: RoW Market for Proteomic Technologies, by Platform Type, Through 2030
Table 84: RoW Market for Proteomic Technologies, by Application Type, Through 2030
Table 85: RoW Market for Biochips, by Type, Through 2030
Table 86: RoW Market for Proteomic Technologies, by Product Type, Through 2030
Table 87: RoW Market for Proteomic Technologies, by Sub-region, Through 2030
Table 88: Rank of Manufacturers in the Proteomics Technology Market, 2024
Table 89: Mergers and Acquisitions in the Proteomics Technology Industry, 2020-2025
Table 90: Agreements, Collaborations and Partnerships in the Proteomics Technology Industry, 2022-2025
Table 91: Product Introductions in the Proteomics Technology Market, 2023-2025
Table 92: Environmental Performance Initiatives in the Proteomics Industry
Table 93: Social Performance Initiatives in Proteomics Market
Table 94: Governance Performance Initiatives in the Proteomics Industry
Table 95: ESG Rankings for Proteomics Companies, 2025*
Table 96: Information Sources for this Report
Table 97: Abbreviations Used in this Report
Table 98: Agilent Technologies Inc.: Company Snapshot
Table 99: Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 100: Agilent Technologies Inc.: Product Portfolio
Table 101: Agilent Technologies Inc: News/Key Developments, 2023 and 2024
Table 102: Arrayit Corp.: Company Snapshot
Table 103: Arrayit Corp.: Product Portfolio
Table 104: Bio-Rad Laboratories Inc.: Company Snapshot
Table 105: Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 106: Bio-Rad Laboratories Inc.: Product Portfolio
Table 107: Bio-Rad Laboratories Inc.: News/Key Developments, 2021 and 2023
Table 108: Bio-Techne: Company Snapshot
Table 109: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 110: Bio-Techne: Product Portfolio
Table 111: Bio-Techne: News/Key Developments, 2024 and 2025
Table 112: Bruker: Company Snapshot
Table 113: Bruker: Financial Performance, FY 2023 and 2024
Table 114: Bruker: Product Portfolio
Table 115: Bruker: News/Key Developments, 2022-2025
Table 116: Creative Proteomics: Company Snapshot
Table 117: Creative Proteomics: Product Portfolio
Table 118: Danaher Corp.: Company Snapshot
Table 119: Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 120: Danaher Corp.: Product Portfolio
Table 121: Danaher Corp.: News/Key Developments, 2024
Table 122: JEOL Ltd.: Company Snapshot
Table 123: JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 124: JEOL Ltd.: Product Portfolio
Table 125: JEOL Ltd.: News/Key Developments, 2023
Table 126: Merck KGaA: Company Snapshot
Table 127: Merck KGaA: Financial Performance, FY 2023 and 2024
Table 128: Merck KGaA: Product Portfolio
Table 129: Merck KGaA: News/Key Developments, 2023 and 2024
Table 130: Promega Corp.: Company Snapshot
Table 131: Promega Corp.: Product Portfolio
Table 132: Revvity: Company Snapshot
Table 133: Revvity: Financial Performance, FY 2023 and 2024
Table 134: Revvity: Product Portfolio
Table 135: Revvity: News/Key Developments, 2023 and 2024
Table 136: Shimadzu Corp.: Company Snapshot
Table 137: Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 138: Shimadzu Corp.: Product Portfolio
Table 139: Shimadzu Corp.: News/Key Developments, 2024 and 2025
Table 140: Standard BioTools: Company Snapshot
Table 141: Standard BioTools: Financial Performance, FY 2023 and 2024
Table 142: Standard BioTools: Product Portfolio
Table 143: Standard BioTools: News/Key Developments, 2024
Table 144: Thermo Fisher Scientific Inc.: Company Snapshot
Table 145: Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 146: Thermo Fisher Scientific Inc.: Product Portfolio
Table 147: Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
Table 148: Waters Corp.: Company Snapshot
Table 149: Waters Corp.: Financial Performance, FY 2023 and 2024
Table 150: Waters Corp.: Product Portfolio
Table 151: Waters Corp.: News/Key Developments, 2023 and 2024
Table 152: Emerging Startups in the Global Proteomics Market
List of Figures
Summary Figure: Share of Global Market for Proteomic Technologies, by Region, 2024
Figure 1: Bottom-Up and Top-Down Proteomics
Figure 2: Porter’s Five Forces Analysis of the Market for Proteomic Technologies
Figure 3: Market Dynamics for Proteomics Technologies
Figure 4: Average Venture Funding for Biopharma Therapeutics and Platform Companies, 2010-2024
Figure 5: Pharmaceutical R&D Expenditures for the U.S., Europe, Japan and China, for 2010, 2020 and 2022
Figure 6: Personalized Medicines and All FDA Approvals, 2015-2023
Figure 7: Patents Related to Proteomics, by Applicant, 2021-March 2025
Figure 8: Share of Patents Related to Proteomics, by Country/Region, 2021-March 2025
Figure 9: Patents Related to Proteomics, by Year, 2010-March 2025
Figure 10: Share of Global Market for Proteomics Technologies, by Platform Type, 2024
Figure 11: Share of Global Market for Proteomics Technologies, by Application Type, 2024
Figure 12: Share of Global Market for Proteomics Technologies, by Platform Type, 2024
Figure 13: Share of Global Market for Proteomic Technologies, by Region, 2024
Figure 14: Share of North American Market for Proteomic Technologies, by Country, 2024
Figure 15: NIH Funding in Healthcare R&D, 2010-2023
Figure 16: Share of European Market for Proteomic Technologies, by Country, 2024
Figure 17: Share of Asia-Pacific Market for Proteomic Technologies, by Country, 2024
Figure 18: Share of RoW Market for Proteomic Technologies, by Sub-region, 2024
Figure 19: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 20: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
Figure 21: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 22: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
Figure 23: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 24: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 25: Bruker: Revenue Share, by Business Unit, FY 2024
Figure 26: Bruker: Revenue Share, by Country/Region, FY 2024
Figure 27: Danaher Corp.: Revenue Share, by Business Unit, FY 2024
Figure 28: Danaher Corp.: Revenue Share, by Country/Region, FY 2024
Figure 29: JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 30: JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 31: Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 32: Merck KGaA: Revenue Share, by Country/Region, FY 2024
Figure 33: Revvity: Revenue Share, by Business Unit, FY 2024
Figure 34: Revvity: Revenue Share, by Country/Region, FY 2024
Figure 35: Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 36: Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 37: Standard BioTools: Revenue Share, by Business Unit, FY 2024
Figure 38: Standard BioTools: Revenue Share, by Country/Region, FY 2024
Figure 39: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 40: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
Figure 41: Waters Corp.: Revenue Share, by Business Unit, FY 2024
Figure 42: Waters Corp.: Revenue Share, by Country/Region, FY 2024
